Alfaro, A. O. V., Vargas, H. C. G., Díaz, J. M., Pinto, J. A., Cambero, D. C. G., Cuellar, E. H., . . . Ponce-Campos, S. D. Anti-IL-5 and anti-IL-5 receptor therapy significantly improves quality of life and FEV1 values in patients with severe asthma. BMC.
Chicago Style (17th ed.) CitationAlfaro, Anaiza Odalis Villalobos, et al. Anti-IL-5 and Anti-IL-5 Receptor Therapy Significantly Improves Quality of Life and FEV1 Values in Patients with Severe Asthma. BMC.
MLA (9th ed.) CitationAlfaro, Anaiza Odalis Villalobos, et al. Anti-IL-5 and Anti-IL-5 Receptor Therapy Significantly Improves Quality of Life and FEV1 Values in Patients with Severe Asthma. BMC.
Warning: These citations may not always be 100% accurate.